Target Audience
PM-M05_01: TB and HIV
- National TB-HIV Collaborative Framework
- NACP and NTEP Coordination at National, State and District Levels
- District AIDS Prevention and Control Units [DAPCU]
- Intensified TB Case Finding [ICF] in HIV testing Settings
- HIV testing of individuals with presumed or confirmed TB
- ART For TB-HIV Patients
- Immune Reconstitution Inflammatory Syndrome [IRIS]
- Co-trimoxazole prophylactic therapy in persons with HIV and TB coinfection
- Isoniazid Preventive Therapy [IPT] in People Living with HIV [PLHIV]
- Linkage to TB-HIV services in the private sector
- Prevention of TB in facilities caring for HIV-infected persons
PM-M05_02: TB and Diabetes
PM-M05_03: TB and other comorbid conditions
- TB Co-morbidities & Special Situations
- Malnutrition among people with TB
- Nutritional Support/ PMTBMBA
- Nutritional Counselling
- Silicosis in people with TB
- Cancer in People with TB
- Alcoholism among people with TB
- Tobacco use among people with TB
- TB in Pregnant and Lactating Women
- DR-TB Treatment in Pregnancy: Recommendation for the Use of Contraception​
- COVID-19 in TB patients
PM-M05_04: Monitoring the comorbidities
- Comorbidity Register
- NTEP Performance Indicator - Percentage of TB Notified Patients with Known HIV Status
- RCA for low performance of Percentage of TB Notified Patients with known HIV Status
- Reporting of ICF activities among PLHIV
- Monitoring of indicators related to TB-HIV
- Monitoring of indicators related to TB-HIV Treatment
- Monitoring of indicators related to TB-HIV prevention
- TB-HIV joint review mechanisms
- Performance Indicators and Targets for TB-HIV Collaborative Activities
- Quarterly report on TB-HIV Collaborative Activities
- Ni-kshay HIV Status Report
Cover
This chapter describes various co-morbidity that can affect the treatment outcomes of TB treatment and efforts to collaborate with other programs to deal TB and its comorbidities effectively.